Skip to main content

Table 1 Baseline characteristics of HGG patients

From: Determining optimal clinical target volume margins in high-grade glioma based on microscopic tumor extension and magnetic resonance imaging

Characteristic

No. (%)

Gender

 

 Male

16 (53.3)

 Female

14 (46.7)

Age (years)

 

  ≤ 60

24 (80)

  > 60

6 (20)

Preoperative KPS

 

 80–90

8 (26.7)

  ≥ 90

22 (73.3)

Pathologic grade

 

 Grade III

17 (56.7)

 Grade IV

13 (43.3)

Tumor volume (cm3)

 

 Median (IQR)

20.04 (10.68–42.92)

 Range

1.83–80.66

PTBE volume (cm3)

 

 Median (IQR)

105.26 (56.92–137.37)

 Range

17.2–235.65

Tumor location

 

 Type I

11 (36.7)

 Type II

9 (30)

 Type III

10 (33.3)

Molecular markers

 

 MGMT methylation status

 

  Unmethylated

12 (40)

  Methylated

18 (60)

 IDH mutation status

 

  Mutated

12 (40)

  Wild type

18 (60)

 1p/19q co-deletion status

 

  Co-deleted

11 (36.7)

  Non-co-deleted

19 (63.3)

  1. HGG high-grade glioma; KPS Karnofsky performance status; IQR interquartile range; PTBE peritumoral brain edema; MGMT O6-methylguanine-DNA-methyltransferase; IDH isocitrate dehydrogenase; 1p/19q co-deletion the co-deletion of chromosome arms 1p and 19q
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us